OFFICE OF FISCAL ANALYSIS

Legislative Office Building, Room 5200

Hartford, CT 06106 (860) 240-0200

http://www.cga.ct.gov/ofa

sHB-5053

AN ACT INCREASING ACCESS TO OVERDOSE REVERSAL DRUGS.

OFA Fiscal Note

State Impact: None

Municipal Impact:

Municipalities

Effect

FY 17 $

FY 18 $

Various Municipalities

Cost

Potential

Potential

Explanation

There is a potential cost, estimated to be less than $10,000 per municipality, associated with: (1) purchasing opioid antagonists, and (2) training emergency service providers to administer opioid antagonists.

This cost will vary based on the type of antagonist and the amount purchased by a municipality. Municipalities that currently purchase and administer opioid antagonists will not incur any cost as a result of the bill.

The bill will not result in a cost to the state employee and retiree health plan, municipal health plans, or the state in accordance with the Affordable Care Act (ACA).1 The state plan and fully insured municipal plans currently provide coverage in accordance with the bill.2

The Out Years

The cost in the out years will vary based on changes in the cost of opioid antagonists, and the cost of training emergency service providers.

1 The state employee and retiree health plan is a self-insured health plan. Pursuant to federal law, self-insured health plans are exempt from state health mandates. However, the state has traditionally adopted all state health mandates.

2 Source: Office of State Comptroller and State Dept. of Insurance